Logo1
ASTS - World Transplant Congress 2014 - Nurse and Pharmacy Professionals ONLY
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
PHARMACISTS AND PHARMACY TECHNICIANS ONLY -- Please provide the following:
NABP eProfile ID (ePID):
Date of Birth (MM/DD) - Example September 24 would be 0924:
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Quality of facilities.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
How appropriate were the learning assessment activities?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
Objective 1: Explain the challenges facing the clinical care of solid organ and tissue transplantation, including potential strategies to optimize patient outcomes.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Objective 3: Assess current treatment and disease prevention strategies for transplant recipients.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
State the basic principle of T cell development
Name the components of the innate and adaptive immune system that impact the response to allografts
Identify where B cells are located during responses to transplants
Discuss potential clinical applications of new molecular diagnostics
Name the current status of molecular transplant diagnostics
Describe a path to consensus in molecular transplant diagnostics
Name the basic parameters that are measured to detect the immune response to infection in the transplant population
State current and emerging techniques that are used to measure these parameters
List specific characteristics of immunity to Epstein Barr virus in the transplant population
Summarize alloantigens and alloimmunity
List the distinction between MHC and other anoantigens
Describe three pathways of MHS allorecognition and their Kinetics
List the effects of the LAS on Transplant Candidate Criteria
State the characteristics of current non-living lung donors
Determine importance of diagnosis of rejection after lung transplantation
Review current status of VAD use as BTT
Name the timing and risk of rejection post transplantation
Explain mechanisms involved in sensitization before heart transplantation
Explain how broadening distribution may impact survival pre- and post-transplant
Discuss potential solutions to the problems with our pediatric liver allocation system
State how to inform participants of the current issues of liver allocation for patients with HCC
Identify various transition program models that can be implemented
Describe the difference between transfer and transition
Summarize key self-management skills and transition readiness
Name the impact of immune deficiency on inflammatory response
Identify the importance of recent and distant epidemiologic exposures in risk
List prevention strategies to avoid MDR transmission recipient's outcome
Explain cellular and molecular mechanisms of immune tolerance to bone marrow and organ transplants
Name the risks and benefits of immune tolerance in kidney transplant patients
Identify how to revascularize a tracheal allotransplant
List the functional elements in the human genome besides genes
Demonstrate of ways in which this approach can be adapted to directly predict drug outcomes such as adverse reactions
State how expression technologies and results can be integrated with genetic and genomic data from transplantation studies
Explain how dendritic cells recognize and respond to the gut microbiota
State differences between transplant arteritis in humans vs. mice
Identify patterns of the human genomic response to severe injury
Describe the frequency and the etiology of pulmonary complications in pediatric non-lung transplant recipients
Identify potential risk factors for pulmonary complications in pediatric non-lung transplant recipients
Discuss assessment and therapy of pulmonary complications in pediatric non-lung transplant recipients
Discuss magnitude of medication non-adherence as a problem in solid organ transplantation
Describe the economic, clinical and social burden of medication non-adherence on
Review state of science regarding interventions fostering improved medication adherence
Review and evaluate the latest clinical and basic science advances in allosensitization
Discuss HLA testing for identifying acceptable donors for the highly sensitized patient
Review the implications of post transplant HLA antibodies on clinical outcomes
State the basic structure of a statistical model
Identify new ways of thinking about statistical concepts
Name implications of distribution of data on outcomes
Define fast tracking and identify institutional resources needed for a safe fast tracking program
Identify liver transplant recipients who are candidates for fast tracking
Name liver transplant recipients who are not candidates for fast tracking
Discuss the pathogenesis of recurrent FSGS and the challenges in treating it
Discuss the role of B7-1 induction in podocytes in recurrent FSGS
Discuss the value of emergent targeted treatment for recurrent FSGS centered on B7-1 induction in podocytes
Name the current indications for fecal microbiota transplantation (FMT)
State key concepts about the human microbiome and its relation to health
Explain specific host-commensal bacteria interactions in human health and disease
Explain the impact of donor selection criteria on the recipient
List appropriate ventilation strategies in the transplant recipient
Identify current status of Ex vivo Lung Perfusion
Develop an approach to screening for malignancy and cardiac allograft vasculopathy (CAV) as the cardiac transplant patient ages
Summarize other problems that are manifested as people age may impact transplant recipients
Name early post-operative management issues
Identify where pharmacogenetic factors explain a large proportion of between-patient variability in either drug pharmacokinetics, or in drug response
Discuss the ins and outs of various endpoints of clinical trials investigating the added value of pharmacogenetics
Calculate the number of patients to genotype in order to preventone acute rejection episode
Discuss limitations of current robotic system.
Discuss new laparoscopic techniques in living donation
Discuss the outcome of laparoscopic and robotic assisted laparoscopic kidney transplantation
Elaborate the technical aspects of left lobe
Compare functional results of donation by lobe
Discuss the propspects of minimal access donation
Examine the role of post-transplant antibodies in solid organ transplant outcome
Review and evaluate the latest clinical and basic science advances in Histocompatibility
Determining antibody specificity risk assessment towards a virtual crossmatch
Name the relevance of alloantibodies in visceral transplantation
State the reasons for different types of intestinal grafts
Discuss intestinal transplantation vs parenteral nutrition risks
Explain the cultural/religious issues related to organ donation in the UK
Explain how to engage with cultural/religious communities on the topic of organ donation
Highlight examples of good practice
Discuss the evaluation process involving multidisciplinary team members
Define advanced practice providers
Identify at least 2 ways in which APPs can support quality care in transplant
State the HIV Organ Policy Equity (HOPE) Act (Public Law 113-51)
Summarize the research criteria under which HIV+ to HIV+ organ transplantation will begin in the US and the process for re-evaluation
Identify and provide a forum for stakeholders to provide public comment and feedback
Discuss the consequences of lacking natural killer cells
Discuss the role of FOXP3 in Treg development and function
Identify factors that influence peripheral Treg generation
Describe the factors influencing pharmacoeconomic outcomes in transplantation
Discuss our current understanding of these factors as it relates to the study of generic immunosuppression in transplantation
Implementing the principles of the Declaration of Istanbul
Identify which sensitized patients require therapy prior to transplant
Discuss the effect of pretransplant allosensitization in heart and lung transplant recipients on waiting times for transplant
Discuss the various aspects of HLA antibody determination regarding specificity, titer and function
Explain how microRNAs regulate immune responses
State how microRNAs can be used a biomarkers of graft status
Summarize the expression of microRNAs in human allografts 2
Explain the impact of living donors on transplantation bottom line
Identify cost accounting of living donors
Name risk factors for poor psychosocial outcomes
Explain the evidence that allows us to determine graft quality
Describe current status of human islet transplantation in type 1 diabetes
Determine the most appropriate indication for islet autotransplantation
State the spectrum of infections occurring in cirrhotic patients
Review splanchnic and systemic organ derangements in decompensated cirrhosis
Outline the pathophysiology of the splanchnic and systemic circulations in decompensated cirrhosis
Describe living kidney donation as a long-term life-altering event
Describe the attitudes of transplant professionals toward live organ donation as a personal option.
Identify aspects of psychosocial status that affect donor candidacy and readiness within the context of paired kidney exchange.
Summarize the current status of clinical trials for tolerance induction
name risks and side effects of each strategy for tolerance induction
Identify what is the evidence that regulatory B cells are involved in transplant tolerance
Name the proportion of children with ESRF have significant physical or intellectual impairment
Explain the justice issues in listing decisions
State the issues around commencing dialysis in these children
Assess the risk of rejection of donor sensitized vs not donor sensitized kidney transplants
Explain short and midterm differences in graft survival associated with these types of transplants
Identify several approaches to decrease risk of donor sensitized kidney transplant
Identify what is the distribution of B cells in the body
Name the major cues guiding B cell movements
Explain how do B cells encouter antigen
Summarize a Novel Approach to Organ-Specific Immunomodulation
State the principles of T cell engineering for immunotherapy
Name application to cancer therapy
Define the need for a common language in evaluating cardiac allograft vasculopathy
Discuss benefits and gaps in the new nomenclature for cardiac allograft vasculopathy
Define CAV Treatment strategies
State the processes involved in biomarker identification, confirmation and validation
Explain how biomarkers may help improve patient care
Define the methods and technologies associated with metabolomics
Identify patients and resultant inability to develop targeted therapies
Summarize the potential use of genomics to predict who is at risk for development of fibrosis and therefore graft loss
Explain if it is possible to prevent early inflammation
Describe the role of alloantibody in liver transplantation
Discuss strategies for addressing alloantibody
Compare the impact of alloantibody on liver and kidney transplants when done simultaneously
Summarize pathologic assessment often guides patient care and research
Describe in vivio microscopy technology and applications
Discuss future in vivo microscopy technologies and opportunities
Present state of DCD practice
Explore the historical origin of the Dead Donor Rule (DDR)
Analyze the social relevance of the DDR
Identify a team that is committed to funding and training local doctors and nurses in kidney transplantation in developing countries
Name complications of transplantation in Africa
Explain what is needed to start a transplant programme
Describe the crisis of organ inavailability
Discuss barriers to individuals becoming live liver donation
Discuss ways to individually tailor the discussion of living donation based on what specific actions the patient is willing to take.
Discuss the usefulness of protocol biopsies
Discuss novel molecular targets for therapy of T cell-mediated rejection
Discuss CTOT structure
Provide the last information on T regulatory cells related to trasnplantation
Identify Tregs can control alloreactivity
Explain the induction of transplantation tolerance using regulatory T lymphocytes in an experimental mouse model
Discuss key correlates/predictors of smoking and alcohol use in adult solid organ transplant recipients
Identify the research questions for the systematic review/meta-analysis
Describe the process of the systematic review/meta-analysis
Define the definitions of primary graft failure
Apply the definition of primary graft dysfunction
Review donor, procedural and recipient risk factors for primary graft dysfunction (PGD)
Identify candidates for treatment
Define expected outcomes from treatment
List the indications for treating HCV post-transplant
Name the effects of obesity on transplant outcomes
Identify the various bariatric procedures in use today
Describe the role of bariatric surgery in the transplant population
Discuss the uncontrolled donation after circulatory death (DCD) process.
Discuss the difference of organ donation operation system between Europe and America
Explain the new categories of organ donation in China-Organ donation after Brain Death followed by Cardiac Death (DBCD)
Discuss the impact of AMR in organ transplantation.
Describe the findings of acute antibody-mediated tissue injury
Discuss how to rapidly translate molecular research data into routine clinical biopsies and get closer to precision diagnosis
Name the differences in the pediatric as compared to the adult immune system
Explain how different vaccines are processed by the immune system by age
List tools to measure immune responses in children
Review recommended infectious disease screening of donors
Identify variability of the time to recognition of disease transmissions
Summarize donor variables associated with risk of transmission of nosocomial infections, geographic endemic infections and blood borne pathogens (HIV, HCV, HBV)
Discuss ethical aspects of living donation
Describe scope of living unrelated donor transplantation
Explain how to increase awareness of the National Living Donor Assistance Center (NLDAC)
Describe the process of necroptosis
Name the different forms of cell death that occur in renal parenchymal cells that affect transplant injury
Explain the impact of RIP3 deletion and loss of necroptosis cell death on transplant outcome
Explain how immune cells are activated and controlled various fates of activated T cells, from effector to apoptosis mechanisms regulating different outcomes of immune responses
Define the role of telomeres in aging
Name the concept of organ aging in health and disease using the kidney as a model organ
Name the use of mechanical ventilation prior to transplant Bridging to transplant with ECMO Transplanting Sensitized Patients
Discuss treatment and long-term impact of AMR on graft outcomes
Review current diagnostic criteria for AMR
Name the process how biomarkers are developed for clinical use in transplantation
Illustrate the molecular biosignature development pipeline in regards to acute rejection of the heart
Explain the role of soluble and cellular immune factors in blood biosignatures
List the current status of portal inflow modification in partial liver transplantation
List the indication and efficacy of splenectomy/splenic artery ligation in partial liver transplantation
Name the role of preformed/newly created portsytemic shunt in partial liver transplantation
Discuss general approach to VCA pathology
Discuss general features of chronic rejection in all solid organ allografts
Discuss specific features of VCA chronic rejection
Identify when is it safe to use marginal donors What are the risks of transferring a second viral strain
List strategies to block the dysregulated and activated immune system in the HIV infected transplant recipients
Explain complicated pharmacologic interactions necessary to provide adequate exposure to immunosuppression in the HIV infected transplant recipient
Explore some models to promote deceased organ donation
Discuss how to increase the rate of brain dead potential donor detection
Discuss how to improve the quality of brain dead organs
Define the need for travel vaccines in transplant patients
Identify cancer risk profile after solid organ transplantation
Review and evaluate the latest clinical and basic science in metabolic syndrome after transplant
Describe the evaluation and monitoring (clinical, pathological and serological) for pulmonary AMR
Summarize the background to pathology of AMR
Define donor HLA specific antibodies
Explain clincal relevance of testing for functional non-HLA antibodies targeting vascular receptors
List new classification of ABMR
Describe prevention of ABMR in kidney transplantation
Summarize criteria for diagnosis of sepsis
Review how this may be different in transplant patients
Name Immune therapies that might prove useful for sepsis in transplant patient
Discuss the needs and potential in diagnostic assessment of HCC
Identify deficiencies in current clinical management of HCC
Discuss the molecular diversity of HCC
Discuss immunological short and long-term outcomes and results according to immunosuppressive protocols
Name differences of immunosuppressive regimens between VCA and solid organ transplants
Review novel immunomodulatory concepts and tolerance strategies for VCA
Discuss Ethical and legal concerns regarding DCD
Discuss requirements for the establishment of a DCD program
Discuss how the development of a deceased donor transplant programme could reduce the need for patients to travel to other countries for transplants
Discuss the current status of vascular rejection in xenotransplantation
Describe the impact of nonGal antigens
Discuss the strategies for regulating B cells responding carbohydrate antigens
Describe two technical barriers to implanted artificial kidneys
List the two components of an implantable artificial kidney
Explain therapy goals for a new kidney device
Discuss allospecific B cell tolerance
Discuss outcome of ABO-incompatible kidney transplantation
Discuss the chemical structure and differential tissue expression of ABO antigens
Summarize the keypoints of living unrelated kidney donation in Iran
Identify a "regulated" system of incentives
Explain ethical concerns of incentives for donation
Explain how increased ischemia affects the impact of endogenous memory T cells on allograft outcome.
Explain how endogenous memory T cells are a critical component of post-reperfusion graft injury
Discuss the role of coinhibitory pathways in alloreactive immune responses
Discuss whether islets of Langerhans require surrounding exocrine tissue for optimal function
Discuss the ultra-structure of the islet-exocrine interface to targeted pancreas digestion during human islet isolation
Discuss the current limitations of islet transplantation Outcomes compared with whole pancreas transplantation
Explain how pigs can be genetically modified to prevent rejection
Describe genetic methods by which innate immunity against porcine xenografts might be prevented or minimized
Discuss alternative source (xenografts from pigs) of human compatible cells and organs for transplantation to over come the shortage of human allografts.
Describe Background of Liver Machine Preservation Present Clinical Results of Machine Preservation Present Molecular findings associated with Liver Machine Preservation
Discuss the technique of ex vivo normothermic machine perfusion of the liver
Discuss the role of preconditioning of ECD livers before transplantation
Develop an approach towards a successful and informative
Explain how biopsies can be helpful and situations when they are not helpful
Illustrate the overlap between infection and rejection associated pathologic changes in the allograft liver
Discuss the clinical, organizational and ethical challenges associated with exchange programs and altruistic unbalanced paired kidney exchange.
Discuss autonomy in living donation
Discuss paternalism consider balance
Discuss some of the potential risks and benefits to donors and recipients of government-controlled kidney donation.
Discuss the financial implications of returning transplant tourists.
Discuss how organ trafficking is an unethical and injustice practice against the poor victims.
Review and evaluate women as caregivers ?in complex chronic disease conditions
Examine broad impact of women caregivers in transplantation on social and policy issues
Investigate developments that have brought women into caregiver roles in the field of transplantation
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

Mr question